Testosterone Enanthate

CAS 315-37-7 4 current records 4 historicalSmall Molecule

Who holds supplier records for Testosterone Enanthate? 4 organisations hold a current record for Testosterone Enanthate: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Germany (1), Italy (1), India (1) and Netherlands (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Testosterone Enanthate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/testosterone-enanthate

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Testosterone Enanthate expires 4 Sept 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Testosterone Enanthate. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • Bayer AG
    Active DMF 3391 · latest filing Oct 1978
    GermanyCEP Company GMP cert on record
  • STEROID SPA
    Active DMF 32765 · latest filing Apr 2018
    ItalyCEP Company GMP cert on record
  • SYMBIOTEC PHARMALAB PRIVATE LTD
    Active DMF 26166 · latest filing Jun 2012
    IndiaCEP Company GMP cert on record
  • ASPEN OSS BV
    Active DMF 3877 · latest filing Jun 1980
    Netherlands Company GMP cert on record
Need Testosterone Enanthate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (3)

Certificates of Suitability on the EDQM register for Testosterone Enanthate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
BAYER AG LeverkusenDE
CEP 2001-155 - Rev 04
Testosterone enantate
Jul 2026—
STEROID S.P.A. Cologno MonzeseIT
CEP 2012-306 - Rev 01
Testosterone enantate
Jul 2026Inspected Feb 2026
Italy
SYMBIOTEC PHARMALAB LIMITED IndoreIN
CEP 2025-080 - Rev 00
Testosterone enantate
May 2026Inspected Mar 2026
Germany

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Testosterone Enanthate are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • ZHEJIANG XIANJU PHARMACEUTICAL CO LTD
    Inactive DMF 27431 · filed Aug 2013
  • BIOVET JOINT STOCK CO
    Inactive DMF 23920 · filed Jun 2010
  • United States · Inactive DMF 4239 · filed Jun 1981
  • ROUSSELL UCLAF
    Inactive DMF 3781 · filed Apr 1980

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (6 listed products contain Testosterone Enanthate). The latest listed patent expires 4 Sept 2036. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Testosterone Enanthate is an esterified variant of testosterone, primarily used in replacement therapy for men who have low testosterone levels. It helps maintain male health by inducing the growth and development of masculine characteristics typical of adult males.

Chemical identity

IUPAC name
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate
Canonical SMILES
CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C
InChIKey
VOCBWIIFXDYGNZ-IXKNJLPQSA-N
Synonyms
Delatestryl API, androtardyl, delatestryl, nsc-17591, testosterone enantate, testosterone enanthate ciii, testosterone heptanoate, testosteroni enantas, xyosted

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Androgen
Mechanism of action
Androgen Receptor Agonists
Chemical structure
Androstanes

Therapeutic areas

EndocrinologyReproductive Health

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Testosterone Enanthate?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Testosterone Enanthate: Bayer AG (Germany), STEROID SPA (Italy), SYMBIOTEC PHARMALAB PRIVATE LTD (India) and ASPEN OSS BV (Netherlands). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Testosterone Enanthate Drug Master Files are active?

Bayer AG (DMF 3391), STEROID SPA (DMF 32765), SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 26166) and ASPEN OSS BV (DMF 3877). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Testosterone Enanthate records mean?

4 organisations have only inactive Type II DMFs for Testosterone Enanthate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Testosterone Enanthate have a European Certificate of Suitability?

Yes. 3 organisations hold a valid CEP for Testosterone Enanthate on the EDQM register, including BAYER AG Leverkusen (DE), STEROID S.P.A. Cologno Monzese (IT) and SYMBIOTEC PHARMALAB LIMITED Indore (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Testosterone Enanthate?

Yes. The latest patent listed for an approved US product containing Testosterone Enanthate expires 4 Sept 2036, across 6 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Testosterone Enanthate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Testosterone Enanthate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.